PD-0332991 is a highly specific inhibitor of cyclin-dependent kinase 4/6 that highly specifically induces G1 phase arrest and thereby inhibits tumor growth (Borghesan et al., 2019). The gene discussed is CDK4; the disease is neoplasm.